Jean Scheftsik de Szolnok

Jean began his career as Chief of Staff of Pharma CEO at Dr Karl Thomae GmbH. Later he moved to Boehringer Ingelheim where over the years, he has held senior roles of Country Manager, General Manager and Vice President in France, Canada, the US, Japan, Belgium and Germany. In 2017, he was appointed President, Boehringer Ingelheim France, responsible for both human pharma and animal health businesses at the critical time of the acquisition of Merial. On 1 January 2020, Jean assumed the role of the Member of the Board of Managing Directors – Boehringer Ingelheim, responsible for Animal Health and is now based in Germany. Jean has a Master Degree in Private and Business Law from the University of Bordeaux, France and completed executive programs in General Management at INSEAD Business School in Fontainebleau, France.